Literature DB >> 17899074

Could choline PET play a role in malignancies other than prostate cancer?

Cristina Nanni, Domenico Rubello, Stefano Fanti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17899074     DOI： 10.1007/s00259-007-0591-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  13 in total

1.  Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001.

Authors:  Aruna V Sarma; David Schottenfeld
Journal:  Semin Urol Oncol       Date:  2002-02

2.  A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer.

Authors:  N Khan; N Oriuchi; H Zhang; T Higuchi; M Tian; T Inoue; N Sato; K Endo
Journal:  Nucl Med Commun       Date:  2003-04       Impact factor: 1.690

3.  In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer.

Authors:  Anthonius J Breeuwsma; Jan Pruim; Maud M Jongen; Albert J Suurmeijer; Wim Vaalburg; Rien J Nijman; Igle J de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-12       Impact factor: 9.236

4.  Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings.

Authors:  Maria Picchio; Uwe Treiber; Ambros J Beer; Stefan Metz; Patrick Bössner; Heiner van Randenborgh; Roger Paul; Gregor Weirich; Michael Souvatzoglou; Rudolf Hartung; Markus Schwaiger; Morand Piert
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

5.  Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging.

Authors:  T Ohtani; H Kurihara; S Ishiuchi; N Saito; N Oriuchi; T Inoue; T Sasaki
Journal:  Eur J Nucl Med       Date:  2001-11

6.  Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.

Authors:  Mei Tian; Hong Zhang; Noboru Oriuchi; Tetsuya Higuchi; Keigo Endo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-11       Impact factor: 9.236

7.  11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.

Authors:  I J de Jong; J Pruim; P H Elsinga; W Vaalburg; H J A Mensink
Journal:  Eur Urol       Date:  2003-07       Impact factor: 20.096

8.  Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas.

Authors:  Toshihiko Hara; Tatsuya Kondo; Tetsuo Hara; Noboru Kosaka
Journal:  J Neurosurg       Date:  2003-09       Impact factor: 5.115

9.  [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients.

Authors:  Marino Cimitan; Roberto Bortolus; Sandro Morassut; Vincenzo Canzonieri; Antonio Garbeglio; Tanja Baresic; Eugenio Borsatti; Annalisa Drigo; Mauro G Trovò
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-25       Impact factor: 10.057

10.  11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.

Authors:  Cristina Nanni; Elena Zamagni; Michele Cavo; Domenico Rubello; Paola Tacchetti; Cinzia Pettinato; Mohsen Farsad; Paolo Castellucci; Valentina Ambrosini; Gian Carlo Montini; Adil Al-Nahhas; Roberto Franchi; Stefano Fanti
Journal:  World J Surg Oncol       Date:  2007-06-20       Impact factor: 2.754
View more
  2 in total

Review 1.  F18-choline/C11-choline PET/CT thyroid incidentalomas.

Authors:  Francesco Bertagna; Domenico Albano; Luca Giovanella; Raffaele Giubbini; Giorgio Treglia
Journal:  Endocrine       Date:  2019-01-12       Impact factor: 3.633

2.  Use of ¹¹C-Choline positron emission tomography/computed tomography to investigate the mechanism of choline metabolism in lung cancer.

Authors:  Zhaoqin Huang; Jun Rui; Xin Li; Xiangjiao Meng; Qingwei Liu
Journal:  Mol Med Rep       Date:  2015-01-14       Impact factor: 2.952
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.